睡眠呼吸中止设备市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

Sleep Apnea Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月19日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球睡眠呼吸中止设备市场价值为 72 亿美元，预计 2025 年至 2034 年的复合年增长率为 7.8%。这一增长是由睡眠呼吸中止症和相关健康状况的患病率上升，以及人们对该疾病及其健康影响的认识不断提高所推动的。全球有数百万人受到睡眠呼吸中止症的影响，但仍有大量病例未被诊断出来。导致盛行率上升的主要因素包括人口老化、肥胖率上升以及生活方式的改变。未经治疗的睡眠呼吸中止症与心血管疾病和糖尿病等严重的健康风险有关，促使更多人寻求医疗干预。人们的认识和诊断能力的提高刺激了对先进睡眠呼吸中止症设备的需求，这些设备有助于有效地管理这种疾病。

睡眠呼吸中止症设备旨在确保睡眠期间呼吸不间断，降低相关健康风险并改善生活品质。这些设备包括 CPAP 和 BiPAP 机器等治疗解决方案，它们仍然是治疗阻塞性睡眠呼吸中止症的首选。 CPAP 机器提供稳定的气流以保持气道畅通，而 BiPAP 设备则针对更复杂的情况提供可调节的压力。设备技术的不断进步，包括更安静的操作和更强的舒适度，提高了患者对治疗的依从性。提高这些疗法的依从性有助于长期管理睡眠呼吸暂停，从而提高销售并促进市场发展。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	72亿美元
预测值	150亿美元
复合年增长率	7.8％

市场按产品细分为诊断和治疗，其中治疗在 2024 年的收入最高，为 46 亿美元。家庭护理领域在 2024 年占据主导地位，预计到 2034 年将达到 89 亿美元。患者可以避免与医院就诊相关的费用，同时还可以享受价格实惠且有保险支援的设备。远距医疗的采用透过实现远端监控和个人化治疗调整进一步增强了家庭护理的吸引力。这种远距科技的整合使得家庭治疗更有效率和便捷。

2024 年美国市场收入为 25 亿美元，预计到 2034 年复合年增长率为 7.4%。私人医疗保健提供者以快速的服务和最先进的治疗而闻名，在市场扩张中发挥着至关重要的作用。

产业生态系统分析
产业衝击力
- 成长动力
  - 睡眠呼吸中止症及相关合併症的发生率不断上升
  - 对便携式、高效能睡眠呼吸中止症解决方案的需求不断增长
  - 人们对睡眠呼吸中止症和睡眠障碍的认识不断提高
  - 老化人口增加，需求增加
- 产业陷阱与挑战
  - 缺乏对睡眠呼吸中止症治疗的依从性
成长潜力分析
技术格局
未来市场趋势
差距分析
监管格局
报销场景
波特的分析
PESTEL 分析

第四章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
公司市占率分析
竞争定位矩阵
策略仪表板

第 5 章：市场估计与预测：按产品，2021 年至 2034 年

主要趋势
疗法
- 气道清除系统
- 气道正压通气 (PAP) 装置
  - 持续性呼吸道正压通气 (CPAP) 设备
  - 双水平气道正压通气 (BiPAP) 装置
  - 自动气道正压通气 (APAP) 装置
- 自适应伺服通气 (ASV) 设备
- 口腔器具
  - 下颚前移装置
  - 舌固定装置
  - 上颚快速扩弓
  - 护齿套
- 其他疗法
诊断
- 多导睡眠图 (PSG) 设备
  - 动态 PSG 设备
  - 临床 PSG 设备
- 活动记录系统
- 脉搏血氧仪
- 居家睡眠测试 (HST) 设备
  - 类型 2
  - 类型 3
  - 类型 4
- 呼吸描记器

第 6 章：市场估计与预测：依最终用途，2021 年至 2034 年

主要趋势
居家照护机构及个人
睡眠实验室和医院

第 7 章：市场估计与预测：按地区，2021 年至 2034 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第八章：公司简介

Asahi KASEI
BMC
Cadwell
Drive DeVilbiss
FISHER & PAYKEL
Itamar Medical
Philips
LivaNova
natus
NIHON KOHDEN
ResMed
Teleflex
WEINMANN

简介目录

Product Code: 489

The Global Sleep Apnea Devices Market, valued at USD 7.2 billion in 2024, is set to grow at a CAGR of 7.8% from 2025 to 2034. This growth is driven by the rising prevalence of sleep apnea and related health conditions, along with increasing awareness of the disorder and its health implications. Millions worldwide are affected by sleep apnea, but a large number of cases remain undiagnosed. Key factors contributing to the rising prevalence include aging populations, higher obesity rates, and changes in lifestyle patterns. Untreated sleep apnea is linked to serious health risks such as cardiovascular disease and diabetes, prompting more individuals to seek medical intervention. Enhanced awareness and diagnosis have spurred demand for advanced sleep apnea devices, which help manage the condition effectively.

Sleep apnea devices are designed to ensure uninterrupted breathing during sleep, reducing associated health risks and improving quality of life. These devices include therapeutic solutions like CPAP and BiPAP machines, which remain the top choice for managing obstructive sleep apnea. CPAP machines provide a steady airflow to maintain open airways, while BiPAP devices offer adjustable pressures for more complex cases. Continuous advancements in device technology, including quieter operations and enhanced comfort, have increased patient adherence to treatment. Improved compliance with these therapies supports long term management of sleep apnea, driving higher sales and bolstering the market.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$7.2 Billion
Forecast Value	$15 Billion
CAGR	7.8%

The market is segmented by product into diagnostics and therapeutics, with therapeutics generating the highest revenue of USD 4.6 billion in 2024. By end use, the market is divided into home care settings and individuals, as well as sleep laboratories and hospitals. The home care segment dominated in 2024 and is projected to reach USD 8.9 billion by 2034. Home-based treatment options are gaining popularity due to their cost-effectiveness and accessibility. Patients can avoid the expenses associated with hospital visits while benefiting from affordable and insurance-supported devices. The adoption of telemedicine further enhances the appeal of home care by enabling remote monitoring and personalized adjustments to therapy. This integration of remote technologies has made home-based treatments more efficient and convenient.

The US market accounted for USD 2.5 billion in revenue in 2024, with an anticipated CAGR of 7.4% through 2034. Growth in the private healthcare sector, along with increased access to advanced diagnostic and therapeutic solutions, is fueling demand. Private healthcare providers, known for quicker services and state-of-the-art treatments, play a crucial role in the market's expansion.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of sleep apnea and related comorbidities
  - 3.2.1.2 Growing demand for portable, high-performance sleep apnea solutions
  - 3.2.1.3 Surging awareness of sleep apnea and sleep disorders
  - 3.2.1.4 Rising aging population amplifying demand
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Lack of adherence to sleep apnea treatment
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Gap analysis
3.7 Regulatory landscape
3.8 Reimbursement scenario
3.9 Porter’s analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Company market share analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Therapeutics
- 5.2.1 Airway clearance systems
- 5.2.2 Positive airway pressure (PAP) devices
  - 5.2.2.1 Continuous positive airway pressure (CPAP) devices
  - 5.2.2.2 Bilevel positive airway pressure (BiPAP) devices
  - 5.2.2.3 Automatic positive airway pressure (APAP) devices
- 5.2.3 Adaptive servo-ventilation (ASV) devices
- 5.2.4 Oral appliances
  - 5.2.4.1 Mandibular advancement devices
  - 5.2.4.2 Tongue-retaining devices
  - 5.2.4.3 Rapid maxillary expansion
  - 5.2.4.4 Mouth guards
- 5.2.5 Other therapeutics
5.3 Diagnostics
- 5.3.1 Polysomnography (PSG) device
  - 5.3.1.1 Ambulatory PSG devices
  - 5.3.1.2 Clinical PSG devices
- 5.3.2 Actigraphy systems
- 5.3.3 Pulse oximeters
- 5.3.4 Home sleep testing (HST) devices
  - 5.3.4.1 Type 2
  - 5.3.4.2 Type 3
  - 5.3.4.3 Type 4
- 5.3.5 Respiratory polygraph

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Home care settings and individuals
6.3 Sleep laboratories and hospitals

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE